Compare Quest Diagnostics Inc (DGX) vs National Beverage Corp. (FIZZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs National Beverage Corp. — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while National Beverage Corp. trades at $30.52 (market cap $2.89B). The key difference: Quest Diagnostics Inc is far larger — about 8.8× National Beverage Corp.'s market cap, and Quest Diagnostics Inc pays a 1.49% dividend while National Beverage Corp. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and National Beverage Corp. for 33 Days on average.
| DGX | FIZZ | |
|---|---|---|
Market Cap | $25.48B | $2.89B |
Volume | 941,866 | 553,950 |
Sector | Health | Consumer Staples |
52-Week High | $247.45 | $37.73 |
52-Week Low | $173.49 | $29.20 |
Typical Hold Time | 56 Days | 33 Days |
Enterprise Value | $31.23B | $2.84B |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.
The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.
National Beverage Corp. (FIZZ) trades at $30.84, up 4.19% today, showing bullish technical signals despite recent earnings misses. The company maintains solid fundamentals with $1.2B revenue, 14.81% net margin, and strong ROE of 40.13%, though growth has stalled with flat revenue trends. Recent news highlights margin pressure from input costs and a special $3.25 dividend payment in July 2026.
Outlook remains cautious with 50% analyst sell ratings reflecting growth concerns, while technical strength near support at $30 offers short-term stability. Key risks include persistent margin compression and competitive pressures in the beverage sector, though valuation at 16.58 P/E appears reasonable for current earnings power.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About National Beverage Corp.
National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls most of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store-delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.
Read more on FIZZ →
